Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "1"

Research

Risk factors for group A streptococcal pharyngitis and skin infections: A case control study

Group A streptococcal (GAS) infections can trigger an immune-mediated response resulting in acute rheumatic fever. The role of social and environmental risk factors for GAS pharyngitis and skin infections are not well understood.

News & Events

National Diabetes Week (Q&A with Dr Keely Bebbington)

For National Diabetes Week, we sat down with Dr Keely Bebbington to talk about her amazing work in research.

Research

Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 years

There is limited information on changes in FOT outcomes in healthy children beyond the preschool years and the level of bronchodilator responsiveness (BDR)...

Research

Cohort profile: Pregnancy and childhood epigenetics (PACE) consortium

Currently, DNA methylation is the most studied epigenetic phenomenon in large populations

Research

The advent of recombinant allergens and allergen cloning Authors:

When the allergen nomenclature system was adopted in 1986, allergens were identified by their behavior on electrophoresis and chromatography...

Rio Tinto Children’s Diabetes Centre Scholarships

Honours/Masters scholarship - now open Applications are open for our Honours / Masters Scholarships with the purpose of providing funding for

News & Events

Technology proves a gamechanger

Heidi Bucktin likes to think of her family’s life as pre and post continuous glucose monitoring – that’s how markedly different the two periods are in their journey of living with a child with type 1 diabetes.

News & Events

Toddlers and diabetes

Caring for a child with type 1 diabetes is challenging, and perhaps even more so when the child is a toddler. Mindful of this and considering the unique needs of families caring for very young children with type 1 diabetes, PCH's Diabetes Clinic is currently

Research

Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting

The Platform trial In COVID-19 priming and BOOsting (PICOBOO) is a multi-site, adaptive platform trial designed to generate evidence of the immunogenicity, reactogenicity, and cross-protection of different booster vaccination strategies against severe acute respiratory syndrome coronavirus 2 and its variants, specific for the Australian context.